SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-022667
Filing Date
2022-11-07
Accepted
2022-11-07 16:39:34
Documents
73
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q dawn-20220930.htm   iXBRL 10-Q 3717073
2 EX-31.1 dawn-ex31_1.htm EX-31.1 16471
3 EX-31.2 dawn-ex31_2.htm EX-31.2 16513
4 EX-32.1 dawn-ex32_1.htm EX-32.1 10344
5 EX-32.2 dawn-ex32_2.htm EX-32.2 11623
6 GRAPHIC img11722173_0.jpg GRAPHIC 344921
  Complete submission text file 0000950170-22-022667.txt   12236104

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dawn-20220930_pre.xml EX-101.PRE 452420
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dawn-20220930_def.xml EX-101.DEF 334052
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dawn-20220930.xsd EX-101.SCH 72023
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dawn-20220930_lab.xml EX-101.LAB 531981
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dawn-20220930_cal.xml EX-101.CAL 42648
67 EXTRACTED XBRL INSTANCE DOCUMENT dawn-20220930_htm.xml XML 2035228
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94080-1930
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94080-1930 650 484-0899
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40431 | Film No.: 221366066
SIC: 2834 Pharmaceutical Preparations